Die Amis kennen Albo genau so gut wie wir hier im Forum oder die Aktionäre die sich damit beschäftigen, Oder meint ihr, die die drüben biodel gekauft haben haben sich mit dem Thema nicht beschäftigt in was sie investieren!? Klar kommt noch hinzu das der Preis jetzt in einer anderen Liga ist wie vorher. Und neue Aktionäre auf Albo aufmerksam werden, aber die müssen sich genau so einlesen wie es die deutschen müssen für denen der Wert auf einmal interessant wird. Von meiner Seite denke ich das die Aktie erstmal stabil bleibt und viele erstmal abwarten was hier eigentlich geboten wird hier bei Albo. Ist jetzt für alle was neues!
"alten" Albireo-Aktien sind ein halbes Jahr gesperrt und daher erst einmal nicht handelbar. Es sind daher nur die ca 2,1 Mill. Aktien handlbar, die nach dem Biodel-Aktien RS hervorgehen.
Biodel Inc. (BIOD) has announced a 1-for-30 reverse stock split and a name/symbol/CUSIP change. As a result of the reverse stock split and name/symbol/CUSIP change, each BIOD Common Share will be converted into the right to receive approximately 0.033333 (New) Albireo Pharma, Inc. Common Shares. (New) Albireo Pharma, Inc. Common Shares will trade on the Nasdaq Stock Market under the trading symbol “ALBO”. The reverse stock split and name/symbol/CUSIP change will become effective before the market open on November 4, 2016. CONTRACT ADJUSTMENT Effective Date: November 4, 2016 Option Symbol: BIOD changes to ALBO1 Contract Multiplier: 1 Strike Divisor: 1 New Multiplier: 100 (e.g., for premium or strike dollar extensions 1.00 will equal $100) New Deliverable Per Contract: 1) 3 (New) Albireo Pharma, Inc. (ALBO) Common Shares 2) Cash in lieu of approximately 0.3333 fractional ALBO Shares CUSIP: ALBO (New): 01345P106 PRICING Until the cash in lieu amount is determined, the underlying price for ALBO1 will be determined as follows: ALBO1 = 0.033333 (ALBO) DELAYED SETTLEMENT The ALBO component of the ALBO1 deliverable will settle through National Securities Clearing Corporation (NSCC). OCC will delay settlement of the cash portion of the ALBO1 deliverable until the cash in lieu of fractional ALBO Shares is determined. Upon determination of the cash in lieu amount, OCC will require Put exercisers and Call assignees to deliver the appropriate cash amount. DISCLAIMER This Information Memo provides an unofficial summary of the terms of corporate events affecting listed options or futures prepared for the convenience of market participants. OCC accepts no responsibility for the accuracy or completeness of the summary, particularly for information which may be relevant to investment decisions. Option or futures investors should independently ascertain and evaluate allinformation concerning this corporate event(s). The determination to adjust options and the nature of any adjustment is made by a panel of The OCC Securities Committee pursuant to OCC By-Laws, Article VI, Sections 11 and 11A. The adjustment panel is comprised of representatives from OCC and each exchange which trades the affected option. The determination to adjust futures and the nature of any adjustment is made by OCC pursuant to OCC ByLaws, Article XII, Sections 3, 25, or 25A, as applicable. For both options and futures, each adjustment decision is made on a case by case basis. Adjustment decisions are based on information available at the time and are subject to change as additional information becomes available or if there are material changes to the terms of the corporate event(s) occasioning the adjustment. ALL CLEARING MEMBERS ARE REQUESTED TO IMMEDIATELY ADVISE ALL BRANCH OFFICES AND CORRESPONDENTS ON THE ABOVE. For questions regarding this memo, call Investor Services at 1-888-678-4667 or email investorservices@theocc.com. Clearing Members may contact Member Services at 1-800-544-6091 or, within Canada, at 1-800-424-7320, or email memberservices@theocc.com
Albireo Pharma, Inc. Common Shares will trade on the Nasdaq Stock Market under the trading symbol “ALBO”. The reverse stock split and name/symbol/CUSIP change will become effective before the market open on November 4, 2016.
Wenn ich den alten bestand mit dem neuen Kurs in meinen Depot so anschaue dann bitte Sekt.... ach was.... Champagner.... pillepalle... ich kauf gleich den ganzen club :))
Mal schauen wie lange es dauert bis die deutschen Broker umgestellt haben. Meiner Meinung nach hat man jetzt wenigstens wieder richtig viel Luft nach unten. Kurs nach R/S : 19,5 $ naja wir werden es ja sehen
Thread abonnieren
